1532 related articles for article (PubMed ID: 25788231)
1. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
[TBL] [Abstract][Full Text] [Related]
2. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
Douglas PS; Hahn RT; Pibarot P; Weissman NJ; Stewart WJ; Xu K; Wang Z; Lerakis S; Siegel R; Thompson C; Gopal D; Keane MG; Svensson LG; Tuzcu EM; Smith CR; Leon MB
J Am Soc Echocardiogr; 2015 Feb; 28(2):210-7.e1-9. PubMed ID: 25455544
[TBL] [Abstract][Full Text] [Related]
5. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
Makkar RR; Fontana GP; Jilaihawi H; Kapadia S; Pichard AD; Douglas PS; Thourani VH; Babaliaros VC; Webb JG; Herrmann HC; Bavaria JE; Kodali S; Brown DL; Bowers B; Dewey TM; Svensson LG; Tuzcu M; Moses JW; Williams MR; Siegel RJ; Akin JJ; Anderson WN; Pocock S; Smith CR; Leon MB;
N Engl J Med; 2012 May; 366(18):1696-704. PubMed ID: 22443478
[TBL] [Abstract][Full Text] [Related]
8. Two-year outcomes after transcatheter or surgical aortic-valve replacement.
Kodali SK; Williams MR; Smith CR; Svensson LG; Webb JG; Makkar RR; Fontana GP; Dewey TM; Thourani VH; Pichard AD; Fischbein M; Szeto WY; Lim S; Greason KL; Teirstein PS; Malaisrie SC; Douglas PS; Hahn RT; Whisenant B; Zajarias A; Wang D; Akin JJ; Anderson WN; Leon MB;
N Engl J Med; 2012 May; 366(18):1686-95. PubMed ID: 22443479
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
10. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
13. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
[TBL] [Abstract][Full Text] [Related]
14. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts.
Szerlip M; Gualano S; Holper E; Squiers JJ; White JM; Doshi D; Williams MR; Hahn RT; Webb JG; Svensson LG; Kirtane AJ; Cohen DJ; Douglas PS; Alu MC; Crowley A; Tuzcu EM; Makkar RR; Herrmann HC; Babaliaros V; Thourani VH; Leon MB; Kodali SK; Mack MJ
JACC Cardiovasc Interv; 2018 Jan; 11(1):13-20. PubMed ID: 29301644
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
[TBL] [Abstract][Full Text] [Related]
16. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
[TBL] [Abstract][Full Text] [Related]
17. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
[TBL] [Abstract][Full Text] [Related]
19. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.
Makkar RR; Thourani VH; Mack MJ; Kodali SK; Kapadia S; Webb JG; Yoon SH; Trento A; Svensson LG; Herrmann HC; Szeto WY; Miller DC; Satler L; Cohen DJ; Dewey TM; Babaliaros V; Williams MR; Kereiakes DJ; Zajarias A; Greason KL; Whisenant BK; Hodson RW; Brown DL; Fearon WF; Russo MJ; Pibarot P; Hahn RT; Jaber WA; Rogers E; Xu K; Wheeler J; Alu MC; Smith CR; Leon MB;
N Engl J Med; 2020 Feb; 382(9):799-809. PubMed ID: 31995682
[TBL] [Abstract][Full Text] [Related]
20. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
Yakubov SJ; Adams DH; Watson DR; Reardon MJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Schreiber T; Gleason TG; Conte J; Deeb GM; Huang J; Oh J; Byrne T; Caskey M; Popma JJ;
J Am Coll Cardiol; 2015 Sep; 66(12):1327-34. PubMed ID: 26383718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
